Clinical Trials Logo

Clinical Trial Summary

Potential Role of Gastric Lavage by Paraffin Oil in Acute Aluminum Phosphide Poisoning.


Clinical Trial Description

The study aims to investigate the Potential Role of Gastric Lavage by Paraffin Oil in Acute Aluminum Phosphide Poisoning: A Randomized Controlled Clinical Trial ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04499885
Study type Interventional
Source Tanta University
Contact Sherief Abd-Elsalam, ass. prof.
Phone 00201147773440
Email sheriefabdelsalam@yahoo.com
Status Recruiting
Phase N/A
Start date June 1, 2020
Completion date December 10, 2030

See also
  Status Clinical Trial Phase
Completed NCT04916392 - Observation Study of the Pharmacokinetics of Adductor Canal Block
Completed NCT04260113 - Apatinib for Inoperable Advanced Chondrosarcoma N/A
Recruiting NCT05355168 - Neoadjuvant Chemoradiotherapy Combined With Camrelizumab and Nimotuzumab for Esophageal Squamous Cell Carcinoma Phase 1/Phase 2
Recruiting NCT04351308 - Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade Osteosarcoma Phase 2
Active, not recruiting NCT03638375 - TIL and Anti-PD1 in Metastatic Melanoma Phase 1/Phase 2
Recruiting NCT05652673 - Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial N/A
Recruiting NCT05512169 - Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia
Completed NCT04690231 - Apatinib + Ifosfamide and Etoposide for Relapsed or Refractory Osteosarcoma N/A
Completed NCT02719002 - Studying the Performance of OCT C-scan in the Screening for Retinopathy Related to Synthetic Antimalarials N/A
Suspended NCT04824352 - Apatinib Plus IE Chemotherapy (Ifosfamide and Etoposide) for Relapsed or Refractory Osteosarcoma Phase 2